Cutting edge technologies PIMS molecular fingerprint and NPOT molecular network in determination of response to Vedolizumab in a prospective treatment of ulcerative colitis (UC) and Crohn`s disease (CD)

Pierre Eftekhari  1     Matthias Breidert  2    
1 Inoviem Scientific,Illkirch Graffenstaden,France
2 Waid. Zuerich. Hospital,Z├╝rich,Switzerland

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing